Actively Recruiting
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
Led by University of California, San Diego · Updated on 2026-02-25
100
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
U
University of California, San Diego
Lead Sponsor
B
Boston Scientific Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators seek to conduct a prospective study to assess the recurrence of AF in patients with acute AF using a long-term ECG monitoring strategy with an insertable cardiac monitor (ICM), which is clinically indicated in this scenario as part of the standard of care. The investigators hypothesize that patients diagnosed with acute AF in the setting of cardiac surgery will have higher rates of AF recurrence than acute AF diagnosed in the setting of non-cardiac surgery or medical illness.
CONDITIONS
Official Title
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient has an existing clinical indication for implantation of an insertable cardiac monitor (ICM) and will undergo ICM implantation as part of their standard medical care.
- Patient is scheduled to receive or has received a Boston Scientific LUX-DX122; insertable cardiac monitor.
- Episode of acute AF detected in an acute care setting or during an acute illness, confirmed by 12-lead ECG and 24-hour ECG or telemetry monitoring.
- Patient or legally authorized representative signs and dates the patient consent form.
- Patient is 18 years old or older.
- Patient is willing and able to comply with all study procedures and attend the required follow-up visits for the duration of the study.
You will not qualify if you...
- Patient has a known history of AF or atrial flutter prior to the index acute AF episode.
- Patient has another indication for antiarrhythmic medications independent of the acute AF episode.
- Patient has a permanent contraindication to oral anticoagulation that would prevent future AF management with anticoagulants.
- Patient is currently enrolled in another clinical trial affecting this study's objectives or endpoints.
- Patient's life expectancy is less than one year.
- Patient is pregnant.
- Patient currently needs implantation of a cardiac implantable electronic device (CIED) or an implantable hemodynamic monitoring system.
- Patient is not fit, able, or willing to follow the required study procedures.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sulpizio Cardiovascular Center
La Jolla, California, United States, 92037
Actively Recruiting
Research Team
B
Benjamin U Hoffman, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here